Given that Syrosingopine targets MCT1 and MCT4, and UK-5099 targets MPC1 and MPC2, we conducted RT-qPCR to assess the expression of these targets in NSCLC cell lines, including H1792, A549, H23, H661, H1299, H1975, PC-9, H2030, and YTMLC-90. The gene discussed is SLC16A1; the disease is non-small cell lung carcinoma.